Skip to main content

Table 3 Probability of time the concentration is four times MIC attainment for Pseudomonas spp.

From: Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy

Antibiotic, daily dose (number of patients)

Time period (number of series)

PK/PD target attainment (number of series (%))

MEM 1 g

twice daily (n = 17)

All (n = 22)

18 (81%)

 

Day < 48 hours (n = 7)

5 (71%)

 

Days > 48 hours (n = 15)

13 (87%)

TZP 4 g

four times daily (n = 16)

All (n = 21)

15 (71%)

 

Day < 48 hours (n = 12)

8 (66%)

 

Days > 48 hours (n = 9)

7 (78%)

FEP 2 g

twice daily (n = 8)

All (n = 11)

0 (0%)

 

Day < 48 hours (n = 7)

0 (0%)

 

Days > 48 hours (n = 4)

0 (0%)

CAZ 2 g

twice daily (n = 12)

All (n = 15)

8 (53%)

 

Day < 48 hours (n = 8)

3 (38%)

 

Days > 48 hours (n = 7)

5 (71%)

  1. Probability of target time that the concentration is four times the minimum inhibitory concentration (MIC) attainment for Pseudomonas spp. in the early (< 48 hours) and late (48 hours) phases of sepsis: meropenem (MEM), ≥ 40% of time above 8 μg/ml; piperacillin-tazobactam (TZP), ≥ 50% of time above 64 μg/ml; cefepime (FEP) and ceftazidime (CAZ), ≥ 70% of time above 32 μg/ml. PK/PD, pharmacokinetic/pharmacodynamic.